Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 16.48
+0.09 (0.55%)
Jun 18, 2026, 3:04 PM CST
Hualan Biological Vaccine Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Hualan Biological Vaccine stock has a consensus rating of "Strong Buy" and an average price target of ¥26.84. The average 1-year stock price forecast is 62.86% higher than the current stock price, while the lowest is ¥23.68 (+43.69%) and the highest is ¥30.00 (+82.04%).
Price Target: ¥26.84 (+62.86%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Hualan Biological Vaccine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | Jun '25 | Dec '25 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 1 | 2 | 2 |
Financial Forecast
Revenue This Year
1.40B
from 1.20B
Increased by 16.26%
Revenue Next Year
1.60B
from 1.40B
Increased by 14.45%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | ||
| Avg | 1.4B | ||
| Low | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.3% | ||
| Avg | 16.3% | ||
| Low | 16.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |